Navigation Links
Prometic to present at the American Chemical Society
Date:4/4/2008

MONTREAL, April 4 /PRNewswire-FirstCall/ - ProMetic Life Sciences Inc. (TSX:PLI) ("ProMetic") announced today that Dr. Robert Rohwer, Pathogen Removal and Diagnostics Technology Inc.'s ("PRDT") academic co-founder and Dr. Patrick Gurgel, ProMetic's Senior Research Scientist will present at the American Chemical Society's ("ACS") 235th National Meeting in New Orleans from April 6 - 10, 2008. Drs Rohwer and Gurgel will be speaking during the symposium honoring Dr. Ruben Carbonell's nomination as Fellow of the Industrial and Engineering Chemistry ("I&EC") Division of the ACS.

Dr. Carbonell is an academic co-founder of PRDT, a ProMetic joint venture with the American Red Cross, along with Dr. Robert Rohwer.

Dr. Rohwer will be speaking on April 7, 2008 at 16:25 (EDT) and the title of his presentation is "Managing the risks from blood-associated TSE infectivity with prion affinity ligands".

Dr. Gurgel's lecture titled "Development of a device for prion reduction based on affinity ligand" will be presented on April 8, 2008 at 13:30 (EDT)

The accompanying presentations will be available on ProMetic's website at http://www.prometic.com/en/scientific_information_et.htm following the respective lecture.

About PRDT Academic co-founders

Dr. Ruben Carbonell, is the Frank Hawkins Kenan Distinguished Professor of Chemical and Biomolecular Engineering, and Director of the Golden LEAF Biomanufacturing Training and Education Center ("BTEC") at North Carolina State University. Dr. Carbonell's recent research in bioseparations led to the identification of a specific ligand for the prion protein responsible for the transmission of mad cow disease in humans. This ligand is being used to remove prion protein from blood products. Dr. Carbonell is the recipient of a number of teaching and research awards, including NC State's Alumni Distinguished Graduate Prof
'/>"/>

SOURCE PROMETIC LIFE SCIENCES INC.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. ProMetic and MacoPharma announce successful completion of P-Capt(R) prion reduction filter clinical studies
2. ProMetic announces scale-up of prion removal resin in plasma product for biopharmaceutical use
3. ProMetic provides business update - Over $35 million worth of business secured in January
4. ProMetic announces signature of definitive license agreement with Kedrion for two hyperimmune products
5. ProMetic reports continued positive data in PBI-1402 phase II trial in chemotherapy-induced anemia
6. ProMetic and Sartorius Stedim Biotech collaborate on technology transfer deals in Asia
7. Imagenetix Inc. to Present at Noble Small Cap Financial Conference on August 21, 2007
8. Avicena Group to Present at Noble Financial Conference
9. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
10. Strategic Diagnostics to Present at Two Upcoming Investor Conferences
11. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... , , QUEBEC CITY, Dec. 2 /PRNewswire-Firs...X: AEZ) (the "Company"), a global biopharmaceutica...y, today announced that the U.S. Food and Drug Adm...on for the Company,s PI3K/Akt pathway inhibitor co...f relapsed/refractory multiple myeloma. Keryx Biop...
(Date:12/2/2009)... , , HOBOKEN, N.J., Dec. 2 /PRNewswire/ ...40 percent to 45 percent of Americans diagnosed wi...tinopathy. Diabetic retinopathy, damage to the re...se of blindness in people with diabetes and is one...ct, up to 80 percent of all patients who,ve had di...
(Date:12/1/2009)... , , NEW YORK, Dec. 1 /PRNewswire/ ...search report is available in its catalogue: ,,.../www.reportlinker.com/p0164494/Chromium---Global-M...mium is primarily influenced by stainless steel, w...e markets is also important for growth of chromium...
(Date:12/1/2009)... , , PLYMOUTH, Mass., Dec. 1 /PRNewswire/...om ) announced today results from the company spon...amachandra Medical Center in Chennai, India using ...on-reconstructable Critical Limb Ischemia (CLI). S... international-associated institution based in Che...
Breaking Biology Technology:AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 2Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 4Reportlinker Adds Chromium - Global Market Trends 2Reportlinker Adds Chromium - Global Market Trends 3Reportlinker Adds Chromium - Global Market Trends 4Reportlinker Adds Chromium - Global Market Trends 5Reportlinker Adds Chromium - Global Market Trends 6Reportlinker Adds Chromium - Global Market Trends 7Reportlinker Adds Chromium - Global Market Trends 8Reportlinker Adds Chromium - Global Market Trends 9Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 2Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 3
...other twist on the strangeness of the nanoworld, r...and Technology (NIST) and the University of Maryla...h as silica that are quite brittle in bulk form be...sults may affect the design of future nanomachines... Kim and colleagues first demonstrated* the latest...
...CELAND, March 12 deCODE genetics,(Nasdaq: DCGN )...s for the,quarter and year ended December 31, 2007...and operating highlights will be webcast live tomo... (details below)., Net loss for the year ended De...5 million for the full year 2006. Basic and dilute...
...N JOSE, Calif., March 12 Oncolys BioPharma,Inc. (...ose, CA, USA),announced today that they have enter... to develop and commercialize throughout Asia, Tac...rus (HCV) compound, TT-033,code-named by Oncolys a...gic alliance entered into by Tacere and Oncolys in...
Other Biology Technology:Nanomaterials show unexpected strength under stress 2deCODE Genetics Announces Full-year 2007 Financial Results 2deCODE Genetics Announces Full-year 2007 Financial Results 3deCODE Genetics Announces Full-year 2007 Financial Results 4deCODE Genetics Announces Full-year 2007 Financial Results 5deCODE Genetics Announces Full-year 2007 Financial Results 6deCODE Genetics Announces Full-year 2007 Financial Results 7deCODE Genetics Announces Full-year 2007 Financial Results 8deCODE Genetics Announces Full-year 2007 Financial Results 9Oncolys BioPharma and Tacere Therapeutics Sign Strategic Alliance and License Agreement to Develop and Commercialize RNAi Hepatitis C Drug 2Oncolys BioPharma and Tacere Therapeutics Sign Strategic Alliance and License Agreement to Develop and Commercialize RNAi Hepatitis C Drug 3
(Date:12/1/2009)...sease, nerve cell degeneration plays a crucial rol...ibly be derived from steering the generation and/o...blished in the current issue of the renowned journ...go, neurogenesis the process of nerve cell develo...t brain. The textbooks asserted that dead nerve ce...
(Date:12/1/2009)...hnology has been awarded a U.S. Air Force Center o...arvesting and adaptive materials, and to develop t...he modern warfighter. , The $10.5 million Cente... Nanostructures and Improved Cognition (BIONIC) ce... Sandhage, professors in Georgia Tech,s School of ...
(Date:12/1/2009)... attacks by sharks can be solved with a new techni...mp they put on their victims, according to a Unive...In a method analogous to analyzing human fingerpri...ely comparing shark bites to the jaws and teeth of...ctor of the International Shark Attack File, which...
Breaking Biology News(10 mins):New source discovered for the generation of nerve cells in the brain 2Air Force Center of Excellence awarded in nanostructures and improved cognition 2Air Force Center of Excellence awarded in nanostructures and improved cognition 3Air Force Center of Excellence awarded in nanostructures and improved cognition 4New forensic technique gives clues about sharks from bite damage 2New forensic technique gives clues about sharks from bite damage 3Traveling With Diabetes The Positive Way 55962 1Traveling With Diabetes The Positive Way 55962 2Traveling With Diabetes The Positive Way 55962 3Two Year SYNTAX Data Show Comparable Safety Outcomes for Complex Patients Treated With TAXUS 28R 29 EXPRESS 28R 29 Stents and Bypass Surgery 4934 1Two Year SYNTAX Data Show Comparable Safety Outcomes for Complex Patients Treated With TAXUS 28R 29 EXPRESS 28R 29 Stents and Bypass Surgery 4934 2Two Year SYNTAX Data Show Comparable Safety Outcomes for Complex Patients Treated With TAXUS 28R 29 EXPRESS 28R 29 Stents and Bypass Surgery 4934 3Two Year SYNTAX Data Show Comparable Safety Outcomes for Complex Patients Treated With TAXUS 28R 29 EXPRESS 28R 29 Stents and Bypass Surgery 4934 4Two Year SYNTAX Data Show Comparable Safety Outcomes for Complex Patients Treated With TAXUS 28R 29 EXPRESS 28R 29 Stents and Bypass Surgery 4934 5SOKO Fitness 26 Spa Group Announces Record Financial Results for Fiscal Year 3B Sets Conference Call to Discuss Results 55954 1SOKO Fitness 26 Spa Group Announces Record Financial Results for Fiscal Year 3B Sets Conference Call to Discuss Results 55954 2SOKO Fitness 26 Spa Group Announces Record Financial Results for Fiscal Year 3B Sets Conference Call to Discuss Results 55954 3SOKO Fitness 26 Spa Group Announces Record Financial Results for Fiscal Year 3B Sets Conference Call to Discuss Results 55954 4SOKO Fitness 26 Spa Group Announces Record Financial Results for Fiscal Year 3B Sets Conference Call to Discuss Results 55954 5SOKO Fitness 26 Spa Group Announces Record Financial Results for Fiscal Year 3B Sets Conference Call to Discuss Results 55954 6SOKO Fitness 26 Spa Group Announces Record Financial Results for Fiscal Year 3B Sets Conference Call to Discuss Results 55954 7SOKO Fitness 26 Spa Group Announces Record Financial Results for Fiscal Year 3B Sets Conference Call to Discuss Results 55954 8SOKO Fitness 26 Spa Group Announces Record Financial Results for Fiscal Year 3B Sets Conference Call to Discuss Results 55954 9
...ding on newly discovered genetic threads in the ri...er, a Johns Hopkins Kimmel Cancer Center team has ... those signals with a statin and an experimental a...ol-lowering lovastatin and cyclopamine killed 63 p...atory. By contrast, using either agent alone wipe...
...ct detection of base sequence in duplex nucleic ac...s Research will publish "Heteropolymeric Triplex-B...Nucleotide Polymorphisms in Human Genomic Samples"...r-reviewed, open access, online journal, PLoS ONE....elating to the assay of pathogens in samples also ...
...ntists at Rice University and pediatric specialist...new way to use Rice,s famed buckyball nanoparticle...lls. , The research appears in the Jan. 21 issue o... , All living cells defend themselves by walling...form a protective cocoon around the cell,s inner m...
Other Biology News:Statin plus cancer drug deliver combo punch to brain cancer cells 2Triplex assay used to assay duplex genomic DNA 2Buckyballs used as 'passkey' into cancer cells 2
Terrific Broth from GE Healthcare, formerly Amersham Biosciences
Mouse Anti-Human VEGF R3 / Flt-4 Monoclonal Antibody, Phycoerythrin Conjugated, Clone 54733 from R&D Systems
Goat Anti-Human Legumain Polyclonal Antibodies, from R&D Systems
Mouse Anti-Human Cystatin F Monoclonal Antibodies, 292103 from R&D Systems
Biology Products: